MANAGEMENT OF ENDOCRINE DISEASE: Regenerative therapies in autoimmune Addison's disease.

@article{Gan2017MANAGEMENTOE,
  title={MANAGEMENT OF ENDOCRINE DISEASE: Regenerative therapies in autoimmune Addison's disease.},
  author={Earn Hui Gan and Simon H S Pearce},
  journal={European journal of endocrinology},
  year={2017},
  volume={176 3},
  pages={
          R123-R135
        }
}
  • E. Gan, S. Pearce
  • Published 1 March 2017
  • Medicine
  • European journal of endocrinology
The treatment for autoimmune Addison's disease (AAD) has remained virtually unchanged in the last 60 years. Most patients have symptoms that are relatively well controlled with exogenous steroid replacement, but there may be persistent symptoms, recurrent adrenal crisis and poor quality of life, despite good compliance with optimal current treatments. Treatment with conventional exogenous steroid therapy is also associated with premature mortality, increased cardiovascular risk and… Expand
Residual Adrenal Function in Autoimmune Addison’s Disease—Effect of Dual Therapy With Rituximab and Depot Tetracosactide
TLDR
Combined treatment with rituximab and depot tetracosactide did not restore normal adrenal function, and adrenocortical plasticity is demonstrated in some patients, and this has the potential to be exploited to improve adrenalfunction. Expand
Epidemiology, pathogenesis, and diagnosis of Addison’s disease in adults
TLDR
Standard care treatments including the management of patients during pregnancy and adrenal crises consistent with the recent consensus statement of the European Consortium and the Endocrine Society Clinical Practice Guideline are described. Expand
Latent Adrenal Insufficiency: From Concept to Diagnosis
TLDR
Diagnosis is established by unequivocally low morning serum cortisol/aldosterone and elevated ACTH and renin concentrations and a standard dose Cosyntropin stimulation test may be needed to confirm adrenal insufficiency (AI) in partial deficiencies. Expand
Adrenal insufficiency
TLDR
The importance of identifying life-threatening adrenal emergencies (acute AI and adrenal crisis) is highlighted and strategies for prevention, which include patient education, glucocorticoid emergency cards and injection kits, are described. Expand
Residual adrenal function in autoimmune addison s disease effect of dual therapy with rituximab and depot tetracosactide
TLDR
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Expand
ET-traps offer a potential therapeutic tool for use in different autoimmune diseases.
TLDR
Those different autoimmune diseases that might benefit from a tool such as ET-traps, which potently sequester these elevated levels of ET-1, are described. Expand
Cortisol Modulation by Ayahuasca in Patients With Treatment Resistant Depression and Healthy Controls
TLDR
Findings point to new evidence on the modulation of salivary cortisol levels as a result of an ayahuasca session, both in healthy and depressive volunteers. Expand
A Single Dose Of Ayahuasca Modulates Salivary Cortisol In Treatment-Resistant Depression
TLDR
Findings point to new evidence of modulation of ayahuasca on salivary cortisol levels, as cortisol acts in regulation of distinct physiological pathways, emotional and cognitive processes related to etiology of depression, this modulation could be an important part of the antidepressant effects observed with ayahuaco. Expand
Changes in Cortisol but Not in Brain-Derived Neurotrophic Factor Modulate the Association Between Sleep Disturbances and Major Depression
TLDR
Results showed a relationship between changes in CAR and in sleep quality in patients with treatment-resistant depression, which were correlated with the severity of disease, suggesting that cortisol could be a physiological link between sleep disturbance and major depression. Expand
Isolation of a multipotent mesenchymal stem cell-like population from human adrenal cortex
TLDR
This study demonstrates that human adrenal cortex harbours a mesenchymal stem cell-like population and will inform regenerative medicine approaches in autoimmune Addison’s disease. Expand
...
1
2
...

References

SHOWING 1-10 OF 122 REFERENCES
Adrenal steroidogenesis after B lymphocyte depletion therapy in new-onset Addison's disease.
TLDR
New-onset autoimmune Addisons disease should be considered as a potentially reversible condition in some patients, and future studies of immunomodulation in autoimmune Addison's disease may be warranted. Expand
Residual adrenal function in autoimmune Addison's disease: improvement after tetracosactide (ACTH1-24) treatment.
TLDR
This is the first study to demonstrate that established autoimmune Addison's disease is amenable to a regenerative medicine therapy approach. Expand
Autoimmune Addison disease: pathophysiology and genetic complexity
TLDR
It is proposed that local failure of steroidogenesis, causing breakdown of tolerance to adrenal antigens, might be a key factor in disease progression. Expand
Long-lasting subclinical Addison's disease.
TLDR
Autoimmune adrenal disease can have a very long preclinical period even with high concomitant ACTH and specific antibody titers. Expand
Estimated risk for developing autoimmune Addison's disease in patients with adrenal cortex autoantibodies.
TLDR
These results were used to construct a risk algorithm for estimating the probability of developing AAD from the combination of gender, age, adrenal function, antibody titer, and associated autoimmune disorders at entry and could be used to decide appropriate follow-up intervals and future immunointervention strategies. Expand
Partial recovery of adrenal function in a patient with autoimmune Addison’s disease
TLDR
If the patient with primary adrenal insufficiency caused by autoimmune adrenalitis is not unique this could have profound effects on treatment and follow-up of Addison’s disease. Expand
Recovery of adrenal function in a patient with confirmed Addison's disease
TLDR
This is the third reported case of spontaneous recovery of the adrenal axis in Addison's disease, and recovery may therefore be more common than previously appreciated, which may have major implications for the treatment and monitoring of this condition, and for the education given to patients at diagnosis. Expand
Spontaneously resolving Addison's disease.
TLDR
A case of a patient with Addison's disease who has had a spontaneous recovery is reported, generally regarded as an irreversible, progressive disease. Expand
Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of addison's disease: a randomized clinical trial.
TLDR
Positive effects on HRQoL were noted with CSHI, indicating that physiological glucocorticoid replacement therapy may be beneficial and that CSHI might become a treatment option for patients poorly controlled on conventional therapy. Expand
Continuous subcutaneous hydrocortisone infusion in Addison's disease.
TLDR
A daily dose of approximately 10 mg/m(2) body surface area/day restores the circadian variation and normal levels of salivary cortisol in most patients, which is close to the estimated daily requirement. Expand
...
1
2
3
4
5
...